Rüdiger von Kummer1, Imanuel Dzialowski2. 1. Institut für Diagnostische und Interventionelle Neuroradiologie, Universitätsklinikum Carl Gustav Carus, Fetscherstr. 74, 01307, Dresden, Germany. ruediger.vonkummer@uniklinikum-dresden.de. 2. Elblandklinikum Meißen, Neurologische Rehabilitationsklinik Großenhain, Nassauweg 7, 01662, Meißen, Germany.
Abstract
PURPOSE: In acute cerebral ischemia, the assessment of irreversible injury is crucial for treatment decisions and the patient's prognosis. There is still uncertainty how imaging can safely differentiate reversible from irreversible ischemic brain tissue in the acute phase of stroke. METHODS: We have searched PubMed and Google Scholar for experimental and clinical papers describing the pathology and pathophysiology of cerebral ischemia under controlled conditions. RESULTS: Within the first 6 h of stroke onset, ischemic cell injury is subtle and hard to recognize under the microscope. Functional impairment is obvious, but can be induced by ischemic blood flow allowing recovery with flow restoration. The critical cerebral blood flow (CBF) threshold for irreversible injury is ~15 ml/100 g × min. Below this threshold, ischemic brain tissue takes up water in case of any residual capillary flow (ionic edema). Because tissue water content is linearly related to X-ray attenuation, computed tomography (CT) can detect and measure ionic edema and, thus, determine ischemic brain infarction. In contrast, diffusion-weighted magnetic resonance imaging (DWI) detects cytotoxic edema that develops at higher thresholds of ischemic CBF and is thus highly sensitive for milder levels of brain ischemia, but not specific for irreversible brain tissue injury. CONCLUSION: CT and MRI are complimentary in the detection of ischemic stroke pathology and are valuable for treatment decisions.
PURPOSE: In acute cerebral ischemia, the assessment of irreversible injury is crucial for treatment decisions and the patient's prognosis. There is still uncertainty how imaging can safely differentiate reversible from irreversible ischemic brain tissue in the acute phase of stroke. METHODS: We have searched PubMed and Google Scholar for experimental and clinical papers describing the pathology and pathophysiology of cerebral ischemia under controlled conditions. RESULTS: Within the first 6 h of stroke onset, ischemic cell injury is subtle and hard to recognize under the microscope. Functional impairment is obvious, but can be induced by ischemic blood flow allowing recovery with flow restoration. The critical cerebral blood flow (CBF) threshold for irreversible injury is ~15 ml/100 g × min. Below this threshold, ischemic brain tissue takes up water in case of any residual capillary flow (ionic edema). Because tissue water content is linearly related to X-ray attenuation, computed tomography (CT) can detect and measure ionic edema and, thus, determine ischemic brain infarction. In contrast, diffusion-weighted magnetic resonance imaging (DWI) detects cytotoxic edema that develops at higher thresholds of ischemic CBF and is thus highly sensitive for milder levels of brain ischemia, but not specific for irreversible brain tissue injury. CONCLUSION: CT and MRI are complimentary in the detection of ischemic stroke pathology and are valuable for treatment decisions.
Authors: Jens Fiehler; Karina Knudsen; Thomas Kucinski; Chelsea S Kidwell; Jeffry R Alger; Götz Thomalla; Bernd Eckert; Oliver Wittkugel; Cornelius Weiller; Hermann Zeumer; Joachim Röther Journal: Stroke Date: 2004-01-22 Impact factor: 7.914
Authors: J Marc Simard; Mingkui Chen; Kirill V Tarasov; Sergei Bhatta; Svetlana Ivanova; Ludmila Melnitchenko; Natalya Tsymbalyuk; G Alexander West; Volodymyr Gerzanich Journal: Nat Med Date: 2006-03-19 Impact factor: 53.440
Authors: Nils H Petersen; Santiago Ortega-Gutierrez; Anson Wang; Gloria V Lopez; Sumita Strander; Sreeja Kodali; Andrew Silverman; Binbin Zheng-Lin; Sudeepta Dandapat; Lauren H Sansing; Joseph L Schindler; Guido J Falcone; Emily J Gilmore; Hardik Amin; Branden Cord; Ryan M Hebert; Charles Matouk; Kevin N Sheth Journal: Stroke Date: 2019-06-04 Impact factor: 7.914
Authors: Pongpat Vorasayan; Matthew B Bevers; Lauren A Beslow; Gordon Sze; Bradley J Molyneaux; Holly E Hinson; J Marc Simard; Rüdiger von Kummer; Kevin N Sheth; W Taylor Kimberly Journal: Stroke Date: 2019-09-20 Impact factor: 7.914
Authors: Annemieke Ter Telgte; Ashley A Scherlek; Yael D Reijmer; Andre J van der Kouwe; Thijs van Harten; Marco Duering; Brian J Bacskai; Frank-Erik de Leeuw; Matthew P Frosch; Steven M Greenberg; Susanne J van Veluw Journal: Acta Neuropathol Date: 2020-02-27 Impact factor: 17.088
Authors: Marco Duering; Ruth Adam; Frank A Wollenweber; Anna Bayer-Karpinska; Ebru Baykara; Leidy Y Cubillos-Pinilla; Benno Gesierich; Miguel Á Araque Caballero; Sophia Stoecklein; Michael Ewers; Ofer Pasternak; Martin Dichgans Journal: J Cereb Blood Flow Metab Date: 2019-07-25 Impact factor: 6.200
Authors: Grant Mair; Awad Alzahrani; Richard I Lindley; Peter A G Sandercock; Joanna M Wardlaw Journal: Neuroradiology Date: 2020-10-30 Impact factor: 2.804